The epidemiology of enterococci
dc.contributor.author | Chenoweth, C. | en_US |
dc.contributor.author | Schaberg, Dennis R. | en_US |
dc.date.accessioned | 2006-09-11T19:31:44Z | |
dc.date.available | 2006-09-11T19:31:44Z | |
dc.date.issued | 1990-02 | en_US |
dc.identifier.citation | Chenoweth, C.; Schaberg, D.; (1990). "The epidemiology of enterococci." European Journal of Clinical Microbiology & Infectious Diseases 9(2): 80-89. <http://hdl.handle.net/2027.42/47899> | en_US |
dc.identifier.issn | 0934-9723 | en_US |
dc.identifier.issn | 1435-4373 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/47899 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2180711&dopt=citation | en_US |
dc.description.abstract | The enterococci are emerging as a significant cause of nosocomial infections, accounting for approximately 10 % of hospital acquired infections. They are found as normal inhabitants of the human gastrointestinal tract, but may also colonize the oropharynx, vagina, perineal region and soft tissue wounds of asymtomatic patients. Until recently, evidence indicated that most enterococcal infections arose from patients' own endogenous flora. Recent studies, however, suggest that exogeneous acquisition may occur and that person-to-person spread, probably on the hands of medical personnel, may be a significant mode of transmission of resistant enterococci within the hospital. The use of broad-spectrum antibiotics, especially cephalosporins, is another major factor in the increasing incidence of enterococcal infections. These findings suggest that barrier precautions, as applied with other resistant nosocomial pathogens, along with more judicial use of antibiotics may be beneficial in preventing nosocomial spread of resistant enterococci. | en_US |
dc.format.extent | 1333262 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; Friedr. Vieweg & Sohn Verlagsgesellschaft mbH | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Internal Medicine | en_US |
dc.subject.other | Medical Microbiology | en_US |
dc.title | The epidemiology of enterococci | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Medicine, Division of Infectious Diseases University of Michigan Medical School, 3425 Vintage Valley, 48105, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Medicine, Division of Infectious Diseases University of Michigan Medical School, 3425 Vintage Valley, 48105, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 2180711 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/47899/1/10096_2005_Article_BF01963631.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF01963631 | en_US |
dc.identifier.source | European Journal of Clinical Microbiology & Infectious Diseases | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.